B6.129-Abcc8tm1.1Fmas/LaakFmasH

Status

Available to order

EMMA IDEM:07416
International strain nameB6.129-Abcc8tm1.1Fmas/LaakFmasH
Alternative nameSUR1-E1506K mutant
Strain typeTargeted Mutant Strains : Point mutation
Allele/Transgene symbolAbcc8tm1.1Fmas
Gene/Transgene symbolAbcc8

Information from provider

ProviderMarkku Laakso
Provider affiliationDepartment of Medicine
Genetic informationThis mouse has a knock-in mutation in Abcc8, the gene encoding the sulphonylurea receptor SUR1, which constitutes the regulatory subunit of the ATP-sensitive K-channel. In humans, this same mutation causes congenital hyperinsulinism.
Phenotypic informationHomozygous mice develop mild glucose intolerance with age due to a reduction in insulin content in the pancreatic beta-cells. Heterozygous mice are far less affected. Unlike in humans, there is no clear hyperinsulinism in the neonatal period.
Breeding historyBackcrossed to C57BL/6.
References
  • A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1.;Shimomura Kenju, Tusa Maija, Iberl Michaela, Brereton Melissa F, Kaizik Stephan, Proks Peter, Lahmann Carolina, Yaluri Nagendra, Modi Shalem, Huopio Hanna, Ustinov Jarkko, Otonkoski Timo, Laakso Markku, Ashcroft Frances M, ;2013;Diabetes;62;3797-806; 23903354
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

MGI allele-associated human disease models

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • impaired glucose tolerance / IMPC
  • increased lean body mass / IMPC
MGI phenotypes (gene matching)
  • hypoglycemia / MGI
  • no phenotypic analysis / MGI
  • increased insulin secretion / MGI
  • decreased insulin secretion / MGI
  • abnormal insulin secretion / MGI
  • abnormal pancreatic beta cell morphology / MGI
  • impaired glucose tolerance / MGI
  • homeostasis/metabolism phenotype / MGI
  • increased circulating glucose level / MGI
  • decreased circulating glucose level / MGI

Literature references

  • A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1.;Shimomura Kenju, Tusa Maija, Iberl Michaela, Brereton Melissa F, Kaizik Stephan, Proks Peter, Lahmann Carolina, Yaluri Nagendra, Modi Shalem, Huopio Hanna, Ustinov Jarkko, Otonkoski Timo, Laakso Markku, Ashcroft Frances M, ;2013;Diabetes;62;3797-806; 23903354

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).